Duvakitug was generally well tolerated across patient groups and showed similar rates of treatment-emergent adverse events, according to the companies.
Original Source Link
Teva Soars, Sanofi Gains on Strong Trial Results for IBD Treatment
PopularPosts
RecentPosts
Sebastian Bach Names Some of His Favorite Rock Albums (And Why)
Sebastian Bach was asked to pick his five favorite albums...
Honda Nissan merger talks Nikkei reports
In an aerial view, brand new Honda cars are displayed...
Third Federal Judge Sabotages Trump By Reversing Retirement Plan
Senate Republicans cut a deal with Democrats to appoint a...
Victoria Beckham shuts down plastic surgery rumors, credits appearance to ‘clever contouring’
Victoria Beckham is putting an end to rumors she altered...
The DOJ wants a Perplexity executive to testify in its Google antitrust case
A U.S. court ruled in August that Google has a...
A Third Person Has Received a Transplant of a Genetically Engineered Pig Kidney
An Alabama woman has become the third person to receive...
